touchPANEL DISCUSSION for touchIMMUNOLOGY

Listen to leading experts discuss the serious consequences of severe type 2 asthma, how endotyping and biomarkers can help guide treatment selection in such patients, and how recent data and clinical guidelines can inform the long-term management of patients with severe type 2 asthma.

The experts

• Dr Katharine Woessner, Scripps Clinic Medical Group, San Diego, CA, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:  https://touchimmunologyime.org/endotypes-for-treatment-selection-in-severe-T2-asthma/

touchPANEL DISCUSSION for touchRESPIRATORY

Listen to leading experts discuss the serious consequences of severe type 2 asthma, how endotyping and biomarkers can help guide treatment selection in such patients, and how recent data and clinical guidelines can inform the long-term management of patients with severe type 2 asthma.

The experts

• Dr Katharine Woessner, Scripps Clinic Medical Group, San Diego, CA, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:  https://touchrespiratoryime.org/endotypes-for-treatment-selection-in-severe-T2-asthma/

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES

Listen to leading experts consider how to optimize the diagnosis of nontuberculous mycobacterial lung disease (NTM-LD) and how to manage it considering the latest treatment guidelines.

The experts

• Dr Juzar Ali, LSU Health Sciences Center, New Orleans, LA, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Insmed. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: touchinfectiousdiseasesime.org/guideline-based-strategies-ntm-ld

touchEXPERT OPINIONS for touchRESPIRATORY

Listen to leading experts consider how to optimize the diagnosis of nontuberculous mycobacterial lung disease (NTM-LD) and how to manage it considering the latest treatment guidelines.

The experts

• Dr Juzar Ali, LSU Health Sciences Center, New Orleans, LA, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Insmed. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchrespiratoryime.org/guideline-based-strategies-ntm-ld

touchTALKS for touchIMMUNOLOGY

This touchPODCAST is presented by Dr Melinda Gooderham, SKiN Centre for Dermatology, Peterborough, Ontario, Canada.

Listen to Dr Gooderham present the latest data and future directions of systemic therapy for moderate-to-severe atopic dermatitis and how effective treatment can achieve sustained control of symptoms and improve the quality of life of patients and their families.

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:  https://touchimmunologyime.org/systemic-therapy-atopic-dermatitis

touchMDT for touchONCOLOLOGY

Listen to key experts from a multidisciplinary team discuss the latest efficacy and safety data for targeted therapies for thyroid cancer 

 The multidisciplinary team 

• Endocrinologist: Dr Antonio Matrone, Italy

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/personalized-approach-to-treatment-thyroid-cancer-biomarkers-and-targeted-therapies//

touchMDT for touchONCOLOLOGY

Listen to key experts from a multidisciplinary team explore the use of biomarkers in thyroid cancer care and how personalized medicine influences patient outcomes

The multidisciplinary team 

• Pathologist: Dr Peter Sadow, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/personalized-approach-to-treatment-thyroid-cancer-biomarkers-and-targeted-therapies//

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team (MDT) discuss the epidemiology of thyroid cancer, available treatment options, and the role of the MDT in patient care

The multidisciplinary team

• Oncologist: Dr Lori Wirth, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This medical education is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/personalized-approach-to-treatment-thyroid-cancer-biomarkers-and-targeted-therapies//

touchEXPERT OPINIONS for touchNEUROLOGY

Listen to leading sleep medicine experts discuss strategies for the optimal management of excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) or narcolepsy, and share insights and potential implications for clinical practice.

The experts

• Dr Annamaria Iakovou – Northwell Health, Lake Success, New York, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent educational grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:

touchEXPERT OPINIONS for touchRESPIRATORY

Listen to leading sleep medicine experts discuss strategies for the optimal management of excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) or narcolepsy, and share insights and potential implications for clinical practice.

The experts

• Dr Annamaria Iakovou – Northwell Health, Lake Success, New York, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent educational grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:  https://touchrespiratoryime.org/managing-eds-in-osa-or-narcolepsy